Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors

Computational Biology and Chemistry(2020)10.1016/j.compbiolchem.2020.107325Source: DataRank Database

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors is a research paper published in Computational Biology and Chemistry (2020). On theSindex it has a DataRank of 0. It has been cited 91 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access91 citations

Download PDF

Cite:

Linked data & code

nct pdb doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)OA: bronzeTopics (58)IDs (PubMed, PMC)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Rosa María Ribas‐Aparicio ORCID,Gerardo Aparicio‐Ozores ORCID,Juan Arturo Castelán-Vega ORCID,Alicia Jiménez-Alberto ORCID

Live enrichment

PubMed:32623357 PMC:PMC7316061

National Institutes of Health

Grant: P41-GM103311

Swine Innovation Porc

Grant: 20201245

Swine Innovation Porc

Grant: 20201445

Swine Innovation Porc

Grant: 20202136 y 20201438

NIGMS NIH HHS

Grant: P41 GM103311

National Institutes of Health

Grant: 5P41GM103311-36

Resource for Biocomputing Visualization and Informatics

Instituto Politécnico Nacional

bronzeLicense: Elsevier TDM

publisherhttps://ars.els-cdn.com/content/image/1-s2.0-S1476927120304813-ga1_lrg.jpg

publisherhttps://api.elsevier.com/content/article/PII:S1476927120304813?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1476927120304813?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7316061

Europe_PMChttps://europepmc.org/articles/PMC7316061

Fields of Study

0301 basic medicine0303 health sciences03 medical and health sciencesAntiviral AgentsBetacoronavirusCOVID-19Coronavirus 3C ProteasesCoronavirus InfectionsCysteine EndopeptidasesDrug Evaluation, PreclinicalDrug RepositioningHumansMolecular Dynamics SimulationPandemicsPneumonia, ViralProtease InhibitorsProtein ConformationSARS-CoV-2Viral Nonstructural Proteins

MeSH Terms

HumansPneumonia, ViralCoronavirus InfectionsCysteine EndopeptidasesViral Nonstructural ProteinsProtease InhibitorsAntiviral AgentsDrug Evaluation, PreclinicalProtein ConformationMolecular Dynamics SimulationDrug RepositioningPandemicsBetacoronavirusCOVID-19SARS-CoV-2Coronavirus 3C Proteases

Keywords

Molecular dynamics simulationDockingMproCovid-19Sars-cov-2Protein ConformationOrganic ChemistryPneumonia, ViralDrug Evaluation, PreclinicalDrug RepositioningViral Nonstructural ProteinsBiochemistryAntiviral AgentsArticleComputational MathematicsBetacoronavirusCysteine EndopeptidasesStructural BiologyHumansProtease InhibitorsCoronavirus InfectionsPandemicsCoronavirus 3C Proteases

Sustainable Development Goals

SDG 3: 3. Good health

Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors

FAIR Checklist

Authors (4)

Funding (7 grants)

Open Access

Topics

Annotations (Europe PMC)